NCT01527305 – An Open-Label, Prospective, Non-Comparative Study to Evaluate the Efficacy and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia Posted on November 27, 2018 by tsuperadmin -
NCT01157351 – A Fifteen-month, Prospective, Randomized, Active-controlled, Open-label, Flexible Dose Study of Paliperidone Palmitate Compared With Oral Antipsychotic Treatment in Delaying Time to Treatment Failure in Adults With Schizophrenia Who Have Been Incarcerated Posted on November 27, 2018 by tsuperadmin -
NCT02385058 – Double-Blind, Placebo-Controlled, Randomized, Prospective, Two-Stage, Two-Arm Study to Evaluate the Efficaciousness and Safety of a Double Treatment Plan Using a Combination of Mebendazole and Quinfamide for Treating Intestinal Helminthiasis and Amebiasis in the Mexican Population Posted on September 28, 2018 by tsuperadmin -
NCT00036387 – A Randomized, Double-blind Trial of the Safety of Anti-TNF Chimeric Monoclonal Antibody (Infliximab) in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Rheumatoid Arthritis on Standard Disease-modifying Anti-Rheumatic Drug Posted on September 10, 2018 by tsuperadmin -
NCT01059773 – An Exploratory Trial to Assess Naturalistic Safety and Efficacy Outcomes in Patients With Moderate to Severe Plaque Psoriasis Transitiioned to Ustekinumab From Previous Methotrexate Therapy (TRANSIT) Posted on July 3, 2018 by tsuperadmin -
NCT01466673 – Comparative Study of the Effect on Acne With norgestimate Containing Triphasic Oral Contraceptive and Biphasic Preparation Containing Desogestrel Posted on January 23, 2018 by tsuperadmin -
NCT00745901 – An Open Label Study to Evaluate Cycle Control with Ortho Tri-Cyclen Lo (norgestimate/ethinyl estradiol) and Yaz (drospirenone/ethinyl estradiol) in Healthy Sexually Active Females Posted on January 23, 2018 by tsuperadmin -
NCT01394991 – A Randomized, Open-Label, Multicenter Study Evaluating Thrombovascular Events in Subjects With Cancer Receiving Chemotherapy and Administered Epoetin Alfa Once or Three Times a Week for the Treatment of Anemia Posted on January 23, 2018 by tsuperadmin -
NCT02025907 – A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy Posted on October 26, 2017 by tsuperadmin -
NCT00378092 – A Prospective Study of the Clinical Outcome Following Treatment Discontinuation After Remission in First-Episode Schizophrenia Posted on September 16, 2015 by tsuperadmin -